These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25116970)

  • 41. [Methotrexate therapy in psoriasis].
    Bournerias I
    Rev Prat; 2004 Jan; 54(1):52-5. PubMed ID: 15049601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methotrexate and ciclosporin combination for the treatment of severe psoriasis.
    Aydin F; Canturk T; Senturk N; Turanli AY
    Clin Exp Dermatol; 2006 Jul; 31(4):520-4. PubMed ID: 16716153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
    Thomas JA; Aithal GP
    Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION study.
    Saurat JH; Langley RG; Reich K; Unnebrink K; Sasso EH; Kampman W
    Br J Dermatol; 2011 Aug; 165(2):399-406. PubMed ID: 21564071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE).
    Paul C; Lacour JP; Tedremets L; Kreutzer K; Jazayeri S; Adams S; Guindon C; You R; Papavassilis C;
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1082-90. PubMed ID: 25243910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of psoriasis. Part 2. Systemic therapies.
    Lebwohl M; Ali S
    J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Acute methotrexate toxicity in psoriasis].
    Arévalo-López A
    Gac Med Mex; 1999; 135(5):513-6. PubMed ID: 10596492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nail psoriasis successfully treated with intralesional methotrexate: case report.
    Sarıcaoglu H; Oz A; Turan H
    Dermatology; 2011 Feb; 222(1):5-7. PubMed ID: 21228554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Methotrexate in psoriasis: are routine biopsies necessary?].
    Guillaume JC
    Ann Dermatol Venereol; 2006; 133(6-7):513-7. PubMed ID: 16885837
    [No Abstract]   [Full Text] [Related]  

  • 50. Systemic methotrexate therapy for psoriasis: past, present and future.
    Dogra S; Mahajan R
    Clin Exp Dermatol; 2013 Aug; 38(6):573-88. PubMed ID: 23837932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: A multicenter, cohort study.
    Ergun T; Seckin Gencosmanoglu D; Alpsoy E; Bulbul-Baskan E; Saricam MH; Salman A; Onsun N; Sarioz A
    J Dermatol; 2017 Jun; 44(6):630-634. PubMed ID: 27943425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis.
    Affleck A; Goudie A; Smith R
    Clin Exp Dermatol; 2019 Jul; 44(5):591-592. PubMed ID: 30919996
    [No Abstract]   [Full Text] [Related]  

  • 53. A case of aseptic pleuropericarditis in a patient with chronic plaque psoriasis under methotrexate therapy.
    Savoia F; Gaddoni G; Casadio C; Patrizi A; Spadola G; Bassi P; Albertini F; Ballardini G; Briganti E; Casolari S; De Donà D; Menni B; Zanotti M; De Angelis P
    Dermatol Online J; 2010 Feb; 16(2):13. PubMed ID: 20178709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxic epidermal necrosis-like dermatosis induced by the first course of methotrexate.
    Sawada Y; Kawakami C; Nakamura M; Tokura Y; Yoshiki R
    Eur J Dermatol; 2009; 19(4):397-8. PubMed ID: 19467968
    [No Abstract]   [Full Text] [Related]  

  • 55. Methotrexate in psoriasis: consensus conference.
    Roenigk HH; Auerbach R; Maibach H; Weinstein G; Lebwohl M
    J Am Acad Dermatol; 1998 Mar; 38(3):478-85. PubMed ID: 9520032
    [No Abstract]   [Full Text] [Related]  

  • 56. A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis.
    Krueger GG; Gottlieb AB; Sterry W; Korman N; Van De Kerkhof P
    J Dermatolog Treat; 2008; 19(3):146-55. PubMed ID: 18569270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intermittent, short term use of methotrexate for exacerbations of psoriasis.
    Clark AR; Feldman SR
    Int J Dermatol; 1997 Dec; 36(12):954-5. PubMed ID: 9466209
    [No Abstract]   [Full Text] [Related]  

  • 58. Split doses of Methotrexate in patients with moderate to severe Psoriasis.
    Rodríguez-Zúñiga MJM; Cortez-Franco F; Qujiano-Gomero E
    Actas Dermosifiliogr; 2017; 108(6):603-604. PubMed ID: 28173920
    [No Abstract]   [Full Text] [Related]  

  • 59. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
    Bigby M
    Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778
    [No Abstract]   [Full Text] [Related]  

  • 60. Yellow nail pigmentation due to methotrexate.
    Malka N; Reichert S; Trechot P; Barbaud A; Schmutz JL
    Dermatology; 1998; 197(3):276. PubMed ID: 9867364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.